PATENT CLAIM ANALYSIS

Application Number: 15981752
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "464000"]

Abstract:
The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.

Claim (Index 15):
The method according to  claim 9 , wherein the tablet provides a dissolution profile, when tested in USP Apparatus Type 2 Paddle Method at 50 rpm in 500 mL of 0.1 N hydrochloric acid at about 37\u00b0 C., wherein at least about 90% of the bromocriptine mesylate has been released at about 20 minutes.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 93.0
- Lexical Diversity: 1.25926
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14920123', '14088269', '13460452', '13773500', '15286826']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8306742575228522
- 35 USC 102 Novelty (BERT): 0.6719737647660687
- Combined Prediction Score: 0.8148042082471738
- Mean Citation Score: 658.5826119999998
- Max Citation Score: 664.2355
- Similarity Product: 648.7363301238121

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test